LATEST

Controversy surrounds abortion pill accessSoon after FDA expanded access to the “abortion pill” or mifepristone (Mifeprex, Danco Laboratories), some states may be combating the decision.
5 facts to know about the new asthma drugFDA recently approved reslizumab (Cinqair, Teva Pharmaceuticals), an injectable used with other asthma medicines for the maintenance treatment of severe asthma. Here are the top 5 facts to know about Cinqair.
First generic Nasonex availableFDA recently approved the first generic version of Nasonex nasal spray (mometasone furoate monohydrate, Apotex Corp).
National diabetes prevention program saves thousands
National diabetes prevention program saves thousandsDiabetes prevention program found to improve quality and reduces healthcare costs. It will now be covered by Medicare in 2017.
FDA approves Bayer hemophilia A drugFDA recently approved antihemophilic factor VIII (recombinant) (Kovaltry, Bayer) for the treatment of hemophilia A in children and adults.
6 facts to know about the new psoriasis drugFDA approved ixekizumab (Taltz, Eli Lilly and Co.) injection 80 mg/mL for the treatment of moderate-to-severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy.
New anthrax injection availableFDA this week approved obiltoxaximab injection, (Anthim, Elusys Therapeutics), to treat inhalational anthrax.
How FDA aims to support generic opioids
How FDA aims to support generic opioidsFDA issued a draft guidance to support industry in their development of generic versions of approved opioids with abuse-deterrent formulations (ADF), while ensuring that generic ADF opioids are no less abuse-deterrent than the brand-name drug.

Poll

View Results